← Home
/
Aclaris Therapeutics, Inc. (ACRS)
Stock Analysis
Aclaris Therapeutics, Inc. (ACRS)
ACRS
ACRS · Market data
4.42
+1.84%
Updated: 2026-06-18 13:40 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 4.43. Holding above 4.32 keeps the current thesis intact.
✓
Fundamentals
Strong / Negative
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
4.32
↗
Break Above
Confirmation improves above resistance.
4.43
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 4.32
What's Driving ACRS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 4.43 for confirmation and 4.32 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 4.32
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
The nearest decision zone is framed by support around 4.32 and resistance near 4.53. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
📈 Net Income
-19.82M
↘ Negative
🧮 EPS (Basic)
-0.15
↘ Negative
Aclaris Therapeutics, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.